Lee Silverman Voice Treatment® LOUD (LSVT®) is an intensive program devised in the United States to train patients with Parkinson's disease (PD) to speak louder, at normal intensity, while keeping a good voice quality. Four weeks of LSVT® has been shown to increase vocal loudness and improve intelligibility among Japanese-speaking PD patients. However, the long-term effects of LSVT® have not been examined in these patients. . This study aimed to investigate the long-term effects of LSVT® on Japanese-speaking PD patients. . Twenty-one Japanese PD patients underwent a standardized course (four sessions over four consecutive days, for four weeks) of LSVT® at our hospital. Vocal loudness and intelligibility were assessed at the following three time-points: pretreatment (baseline), immediately after treatment, and at the end of the 12 month follow-up (12FU). Sound pressure levels (dB SPL) were measured during the following tasks: sustained phonation of /a/, reading a standardized text, and delivery of a monologue. Three experienced speech-language pathologists, who were blinded to patients' identities and assessment points, assessed speech intelligibility based on recorded audio samples of each participant during the reading and monologue tasks. . Fourteen patients were evaluated at 12FU. Changes in dB SPL from baseline to immediately after treatment were +6.5 dB, +4.2 dB, and +2.8 dB, and those from baseline until 12FU were +4.7 dB, +3.5 dB, and +2.5 dB in sustained phonation of /a/, reading a passage, and delivery of a monologue, respectively. These changes were significant ( < 0.025) in both the baseline-to-immediately-after-treatment and baseline-to-12FU intervals. Intelligibility relative to baseline was significantly improved immediately after treatment, but not at 12FU. . LSVT® had a long-term effect on the vocal loudness of Japanese-speaking PD patients. A short-term effect was seen in intelligibility, however, there was no significant long-term effect.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204176 | PMC |
http://dx.doi.org/10.1155/2020/6585264 | DOI Listing |
Cureus
December 2024
Department of Medical Interpreting, Graduate School of Medicine, Juntendo University, Tokyo, JPN.
Background: Non-Japanese-speaking patients taking medical treatment in Japan face language barriers and lack of language assistance. Language barriers influence all processes from preventive services to treatment, and insufficient communication can affect patient outcomes. Illness perception, which is related to illness-coping behaviors and self-care behaviors, is an important factor for effective treatment, but no studies have investigated the relationship between communication skills and illness perception among non-Japanese-speaking patients.
View Article and Find Full Text PDFBMJ Ment Health
July 2024
Department of Neuropsychiatry, Toho University Faculty of Medicine, Ota-ku, Tokyo, Japan
Background: The fast-growing migrant population in Japan and globally poses challenges in mental healthcare, yet research addressing migrants' mental health treatment engagement remains limited.
Objective: This study examined language proficiency, demographic and clinical characteristics as predictors of early treatment discontinuation among migrants.
Methods: Electronic health record data from 196 adult migrants, identified from 14 511 patients who received mental health outpatient treatment during 2016 and 2019 at three central hospitals in the Tokyo-Yokohama metropolitan region of Japan, were used.
Cureus
April 2024
Therapeutics, Faculty of Sport Sciences, Waseda University, Saitama, JPN.
Disabil Rehabil
December 2024
Department of Neurology, NHO Osaka Toneyama Medical Center, Toyonaka, Osaka, Japan.
Purpose: The Facioscapulohumeral Muscular Dystrophy Health Index (FSHD-HI) is a patient-reported outcome measure developed for patients with FSHD. This study aimed to translate the FSHD-HI into Japanese (FSHD-HI-J), evaluate cultural adaptation, and examine its psychometric properties.
Materials And Methods: We created two forward translations, integrated them into a single Japanese version, and evaluated the back-translated version of the FSHD-HI.
J Clin Med
March 2024
Department of Neurological Surgery, Chiba Cerebral and Cardiovascular Center, Chiba 290-0512, Japan.
: In temporal lobe epilepsy (TLE), estimating the potential risk of language dysfunction before surgery is a necessary procedure. Functional MRI (fMRI) is considered the most useful to determine language lateralization noninvasively. However, there are no standardized language fMRI protocols, and several issues remain unresolved.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!